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chondrogenic phenotype of the MSC was assessed following short-term
(1 week) culture.
Results: Addition of rAC to the culture media of rat articular chondrocytes
led to elevated expression of Sox-9, collagen IIA1, FGF2, TGF beta-1 and
several other chondrogenic markers. Similar results were obtained for
cells grown in monolayer cultures or 3-D collagen scaffolds. Elevated
Sox-9 and collagen IIA1 expression also was observed following rAC
treatment of human chondrocytes from a patient with osteoarthritis. No
changes in the total cell numbers were observed despite these positive
changes in the chondrogenic phenotype, indicating that the primary
effect of rAC was on the differentiation capacity of the cells, rather than
on cell survival. We also evaluated the effect of rAC on rat bone marrow
grown for 1 week, and found that the number of MSC in these cultures
was increased ~2–3-fold as assessed by colony forming units (CFU-F) and
ﬂow cytometry, and that their chondrogenic phenotype was positively
inﬂuenced as well.
Conclusions: Based on these results we suggest that AC is an important
enzyme required to maintain the differentiated phenotype of primary
chondrocytes, and that supplementation of media with rAC results in
improved chondrocyte quality following ex vivo expansion. rAC also
improves the yield of bone marrow-derived MSC from short-term
cultures, and their chondrogenic phenotype as well. rAC may therefore
be an important reagent that can be used to improve the production
of chondrocytes for cartilage repair, either ex vivo or through direct
administration to damaged cartilage sites.
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DETAILED EVALUATION OF CHONDRAL DEFECT REPAIR AND
AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL CELLS
TRANSPLANTATION. A NONHUMAN PRIMATE MODEL
S. Araki, S. Imai, M. Kubo, T. Mimura, K. Nishizawa, H. Ueba. Shiga Univ
of Med Sci., Otsu, Japan
Purpose: Articular cartilage injury remains one of the major concerns
in orthopaedic surgery. Although the repair process of articular cartilage
defects has been studied in many species. The extent and time course of
articular cartilage defect healing in humans are not well described.
Mesenchymal stem cells (MSCs) are an important cell source for cartilage
regeneration. A number of successful results in transplantation MSCs into
cartilage defects have been reported in animal models. However, Clinical
studies of MSCs transplantation for cartilage repair were very few.
Physicians not much know efﬁcacy and safety of MSCs transplantation
for cartilage repair in clinical.
Evaluation of the status of articular cartilage repair and MSCs
transplantation for articular cartilage repair at different time points in
a primate model may provide a healing process, efﬁcacy, safety and
postoperative activity recommendations in clinical.
Methods: Full-thickness osteochondral defects were created on the
medial femoral condyles(5mm in diameters and 5mm in depth) and
trochlea(3mm in diameters and 5mm in depth) of 18 cynomolgus
macaques, and the animals were divided into three groups: MSC, Gel,
and Defect. In the MSC group, the defects were ﬁlled with bone marrow-
derived MSCs embedded in collagen gel. In the Gel group, the defects
were ﬁlled with collagen gel without cells. In the Defect group, the
defects were left empty and additional defect were created on the lateral
femoral condyles(2mm in diameters and 5mm in depth). All groups were
evaluated by gross and histologic examination at 6-, 12- and 24-weeks.
Results: In the defect group, Cartilaginous repair responses failed to
occur in the lager 3mm defects, which was covered only by ﬁbrous scar
tissue. In contrast, hyaline-like articular cartilage was regenerated by
24 weeks in 2mm defects. In the MSC group, the border between bone
and cartilage moved upwards, integrations between native cartilage and
regenerated tissue were improved. After 24 weeks, histological scores
of the MSC group improved and were better than those of two other
control groups.
Conclusions: 2mm diameter full-thickness cartilage defect whose size
were critical for primate knees. In the primate animal model, signiﬁcant
improvements in the extent and quality of cartilage repair were observed
from the 12- to 24-week time points after transplantation of MSCs.
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PROLIFERATIVE AND DIFFERENTIATION POTENTIAL OF STEM
CELLS DERIVED FROM THREE MESENCHYMAL TISSUES IN LATE STAGE
OSTEOARTHRITIC PATIENTS
L. Simion1, G. Shaw2, K. Mashayekhi2, P. Botez1, M. Murphy2, F. Barry2.
1Univ. Med. and Pharmacy, Iasi, Romania; 2REMEDI NUI, Galway, Ireland
Purpose: To asses the presence and biological potential of stem
cells in three mesehchymal tissues (subchondral bone, synovial layer,
periarticular adipose tissue) in late stages osteoarthritic patients, subjects
of total knee replacement (TKR)
Methods: Samples were collected from patients undergoing TKR, plastic
adherent cells cultured in complete aMEM with FGF b for succesive
passages: cell morphology and growth potential was recorded. Flow
cytometric surface cell markers detection for stemness antibodies
was performed. Differentiation assays for three mesenchymal lineages
(osteogenesis adipogenesis chondrogenesis) was assesed by qualitative
and quantitative method. Time lapse life cell imaging of nondiferentiated
cells over 24 hours period was used to determine cell kinetics.
Results: Mesenchymal cells derived from all donors and tissue types
displayed morphology and growth potential of MSCs, were positive
for stemness related antibodies (CD 105, CD 73, CD 90), underwent
differentiation toward three lineages with signiﬁcant differences
between tissue of origin and not between donors. Cell kinetics, recorded
for one donor, was different for adipose derived, synovial derived and
trabecular bone derived MSCs, a paralel could be made between growth
kinetics and recorded cell speed.
Conclusions: Late stage OA derived human tissues (subchondral
trabecular bone, extraarticular adipose tissue and synovial layer
contain phenotypically different MSCs which have different growth and
differentiation potential which could be related with the pathogeny
and progression of OA, further to be investigated; these tissues can be
conssidered as cell source for regenerative therapies.
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TGF-b TYPE II RECEPTOR AS A NOVEL INDICATOR OF CHONDROGENESIS
IN EQUINE BONE MARROW-DERIVED MESENCHYMAL STEM CELLS
K.K. Suter1, K.A. Payne1, V. Yao1, L.A. Fortier2, C.R. Chu1. 1Univ. of
Pittsburgh, Pittsburgh, PA, USA; 2Coll. of Vet. Med., Cornell Univ., Ithaca, NY,
USA
Purpose: Articular cartilage lacks the essential components for self-
repair, often resulting in inadequate healing of isolated cartilage
injury, which can lead to degenerative osteoarthritis (OA). Designing
techniques to improve cartilage repair after injury may prevent or
delay development of OA. Bone marrow-derived mesenchymal stem cells
(MSC) are a promising cell source for articular cartilage regeneration. In
vitro, MSC have been shown to undergo chondrogenic differentiation
in the presence of transforming growth factor b1 (TGF-b1), via a
signaling pathway known to play a key regulatory role in chondrogenesis.
Various knockout studies suggest that the TGF-b type II receptor
(TbR-II) is speciﬁcally important in skeletal muscle formation and
bone morphogenesis, but its role has not been clearly deﬁned in
chondrogenesis. The purpose of this study is to test the hypothesis
that levels of TbR-II can predict the cellular responsiveness of equine
bone marrow-derived MSC to TGF-b1 and are related to subsequent
chondrogenic potential.
Methods: Bone marrow aspirate was collected from the sternum of 9
horses and MSC were isolated and expanded in culture until passage
two. To evaluate chondrogenesis, equine MSC were cultured as pellets in
chondrogenic medium with or without addition of TGF-b1 (10ng/ml).
At Day 21, pellets were collected and pellet area was measured
using a stereomicroscope. Pellets were parafﬁn-embedded, sectioned
and stained with safranin-O/fast green for sulfated glycosaminoglycans
(GAG). The Bern score was used for histological grading with a
higher score indicating higher chondrogenesis. Presence of TbR-II was
analyzed by immunoﬂuorescence (K105, Cell Signaling Technology) and
ﬁve to seven regions of each pellet were imaged with ﬂuorescence
microscopy at 40X. The TbR-II intensity of each region was quantiﬁed
with Visiopharm image analysis software and normalized to the
number of cells. Comparisons between groups were performed using
paired t-tests and correlations were evaluated by Pearson’s correlation.
Statistical analysis was performed using SPSS and p< 0.05 was considered
signiﬁcant.
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Results: Pellets cultured in chondrogenic medium supplemented with
TGF-b1 had a greater pellet area than those cultured in chondrogenic
medium only (p < 0.001). The addition of TGF-b1 to the culture medium
led to positive safranin-O staining and higher Bern scores compared
to pellets cultured without TGF-b1 (p < 0.001). TbR-II intensities were
greater in pellets stimulated with TGF-b1 than in unstimulated pellets
(p = 0.043). Overall, positive correlations were observed between TbR-II
total intensity and measured pellet area (p = 0.033), as well as between
TbR-II intensity and BERN score (p = 0.037).
Conclusions: The results from this study indicate that equine MSC are
responsive to TGF-b1 and can undergo chondrogenic differentiation. This
was observed by the increase in pellet area and higher Bern scores
in the presence of TGF-b1. In addition to these commonly reported
measures, this study also evaluated the intensity of TbR-II following in
vitro chondrogenic differentiation and showed that it increased in the
presence of TGF-b1. This increase suggests that TbR-II may be an indicator
of cellular responsiveness to TGF-b1. The positive correlation observed
between TbR-II levels and BERN scores indicates that TbR-II expression
is important in chondrogenesis and may be a novel predictor of MSC
chondrogenic potential. Using TbR-II as an indicator of chondrogenic
potential thus warrants further investigation as it may lead to improved
cell-based therapies for articular cartilage repair, which may delay or
prevent the development of OA after injury.
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IS THE SECOND MICROFRACTURE STILL USEFUL FOR REPAIR OF
ARTICULAR CARTILAGE DEFECT?
M-D. Truong1, Y-J. Kim2, L-H. Jin3, K-H. Choi1,2, B-J. Kim2,3, T-Z. Li2,
H-R. Kim1, J-W. Park3, B-H. Choi4, S-R. Park4, B-H. Min1,2. 1Dept. of
Molecular Sci. and Technology, Ajou Univ., Republic of Korea, Suwon-Si,
Korea, Republic of ; 2Cell Therapy Ctr., Ajou Univ. Med. Ctr., Republic of
Korea, Suwon-Si, Korea, Republic of ; 3Dept. of Orthopedic Surgery, Sch. of
Med., Ajou Univ., Republic of Korea, Suwon-Si, Korea, Republic of ; 4Dept. of
Physiology, Coll. of Med., Inha Univ., Republic of Korea, Incheon-Si, Korea,
Republic of
Purpose: Microfracture (MFx) is considered as the ﬁrst-line treatment
for full thickness cartilage lesion because of its minimal invasiveness,
technical easiness and high cost-effectiveness. Owing to its advantages,
it can be postulated that MFx can be repeated in spite of time dependant
poor long-term follow-up result. The purpose of this study was to
evaluate whether the second MFx could effectively repair the cartilage
defect which was generated at the spot with previously MF being bone.
Fig. 1. Histologic evaluation of the repaired tissue 8 weeks after MFx.
(A,E,I) normal, (B,F,J) control, (C,G,K) ﬁrst MF, (D,H,L) second MF group.
Methods: Thirty-six New Zealand white rabbits were divided into 3
groups: (1) untreated full-thickness chondral defect, (2) treated with
MFx and (3) the second MFx. The number of mesenchymal stem cells
(MSCs) derived from bone marrow was evaluated by colony forming
unit (CFU) assay. The repaired cartilage was evaluated 8 weeks after the
ﬁrst and second MFx. Cartilage evaluation was done by histology and
biochemical assay and subchondral bone was analyzed by micro-CT.
Results: There was no signiﬁcant difference in the colony formation
between the ﬁrst MFx and second MFx. The repaired cartilage after
the second MFx was comparable with that after the ﬁrst MFx in terms
of histologic score and biochemical results even with slightly lower
density of GAG and type II collagen. Subchondral bone remained severely
damaged in both the ﬁrst and second MFx.
Conclusions: The second MFx showed comparable results to the ﬁrst
MFx in spite of tendency to form lower quality of repaired cartilage in
histologic study.
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CHONDROGENESIS DIFFERENTIATION OF MESENCHYMAL STEM CELLS
FROM HUMAN AMNIOTIC FLUID CULTURED WITH TGF BETA 3
M.F. Bombini, C.S. Mara, A.S. Duarte, K.C. Andrade, C.C. Zuliani,
I.B. Coimbra. State Univ. of Campinas, Campinas, Brazil
Purpose: Recently, adult mesenchymal stem cells (MSCs) have been
focused as an alternative source of cells for cartilage repair. It is accepted
that amniotic ﬂuid is a new source of MSCs, and has characteristics
similar to embryonic stem cells which makes them a potential source
for cell differentiation. Cellular condensation is a required step in the
initiation of mesenchimal chondrogenesis. The aim of this study was to
differentiate cells from amniotic ﬂuid into chondrocytes in high density
micromass culture to evaluate the expression of type II collagen.
Methods: Amniotic ﬂuid from 44 pregnat women was harvested in the
second semester. The samples were set in ﬂasks and cultured. Adherent
cells were selected and expanded until 4th passage to obtain the
appropriate number of cells. The cells were analysed by ﬂow cytometry
and after this process, they were platted in high density micromass
culture system, remaining under this condition by 3 weeks in Dulbecco’s
Modiﬁed Eagle Medium (DMEM) with high glucose and transforming
growth factor-beta-3(TGF-beta 3)in a ﬁnal concentration of 10ng/ml
in micromass culture. After 21 days, cell differentiation was veriﬁed by
western blotting analysis of the secreted collagen II protein in the culture
medium.
Results: Through ﬂow cytometry, expanded cells showed typical cell
surface antigens found in mesenchymal stem cells, such as positivity for
CD90, and negativity for antigens found in haematopoetic lineage. After
21 days in high density micromass culture with TGF beta-3 containing
medium, the expression of type II collagen was observed and conﬁrmed
by western blotting. ﬂuid cells into chondrocytes.
Conclusions: The authors showed amniotic ﬂuid MSCs can be
differentiated in articular chondrocytes under the TGF-beta-3 stimuli,
therefore can be used as a reliable source of MSCs.
Cell Signaling
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COMP BINDS TRANSFORMING GROWTH FACTOR BETA FAMILY
LIGANDS TO ENHANCE THEIR ACTIVITY
C. Acharya1, K.D. Snow1, M. Mo¨rgelin2, E. Hong1, P.E. Di Cesare1, J.H. Yik1,
D.R. Haudenschild1. 1Univ. of California Davis, Sacramento, CA, USA; 2Lund
Univ., Lund, Sweden
Purpose: Cartilage oligomeric matrix protein (COMP) is an important
protein essential for the formation and maintenance of the structural
integrity of cartilage matrix. COMP is a homo-pentamer in which each
monomer comprises an N-terminal coiled-coil domain, epidermal growth
factor (EGF) – like repeats, thrombospondin (TSP)-3 like repeats and
a thrombospondin C-terminal domain. Owing to its repeated modular
structure, COMP can assemble various extracellular matrix components
like collagens and proteoglycans. We hypothesized that if COMP were to
bind to growth factors, it could affect growth factor activity by controlling
how and when the growth factors are presented to the cell surface. The
aim of this study was to examine the mechanism and effect of binding
